Takeda, Amylin terminate obesity deal

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) said it and Amylin Pharmaceuticals Inc. mutually terminated a 2009 deal to co-develop and commercialize obesity compounds. In 2011, the companies discontinu...